Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levi van Hijfte

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Cell and Developmental Biology|October 26, 2020
The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1Thijs C J Verheul, Levi van Hijfte, Elena Perenthaler, et al.
Iscience|January 2, 2023
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling dataLevi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, et al.
Neuro-Oncology Advances|February 17, 2025
Transcriptomic analysis of <i>EGFR</i> co-expression and activation in glioblastoma reveals associations with its ligandsSantoesha A Ghisai, Nastaran Barin, Levi van Hijfte, et al.
Neuro-Oncology|October 17, 2025
T cell immunity in glioma and potential implications for immunotherapy: a systematic reviewRosa Luning, Pim J French, Wouter J F Vanbilloen, et al.
Neuro-Oncology Advances|March 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic targetRosa Luning, Sybren L N Maas, Pim J French, et al.
Nature Communications|January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytomaLevi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.
Acta Neuropathologica|October 9, 2024
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Neuro-Oncology|September 30, 2025
YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|October 26, 2020
The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1Thijs C J Verheul, Levi van Hijfte, Elena Perenthaler, et al.
Iscience|January 2, 2023
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling dataLevi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, et al.
Neuro-Oncology Advances|February 17, 2025
Transcriptomic analysis of <i>EGFR</i> co-expression and activation in glioblastoma reveals associations with its ligandsSantoesha A Ghisai, Nastaran Barin, Levi van Hijfte, et al.
Neuro-Oncology|October 17, 2025
T cell immunity in glioma and potential implications for immunotherapy: a systematic reviewRosa Luning, Pim J French, Wouter J F Vanbilloen, et al.
Neuro-Oncology Advances|March 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic targetRosa Luning, Sybren L N Maas, Pim J French, et al.
Nature Communications|January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytomaLevi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.
Acta Neuropathologica|October 9, 2024
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytomaSantoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Neuro-Oncology|September 30, 2025
YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.
Pageof 2